Trial of bromelians (NexoBrid) in patients aged 4-55 years with deep-partial and full-thickness burns
Phase of Trial: Phase III
Latest Information Update: 20 Oct 2015
At a glance
- Drugs Bromelains (Primary)
- Indications Burns
- Focus Registrational; Therapeutic Use
- Sponsors MediWound
- 20 Oct 2015 According to MediWound media release, bromelain topical (NexoBrid) has been authorized for marketing in Argentina by the Ministry of Health in Argentina.
- 30 Mar 2015 New trial record
- 23 Mar 2015 Results published in the Media Release.